Join Now

Category Archives: BioUtah News

Academia in Action: Searching for rare disease treatments

By their very nature, rare diseases impact a smaller portion of the population compared to conditions like cancer or the flu. While these diseases are less common, those affected by them, along with University of Utah researchers, are actively searching for a cure. Treating patients as individuals: Clement Chow Read more about Clement Chow’s research […]

| Comments Off on Academia in Action: Searching for rare disease treatments

CLENE REPORTS SIGNIFICANTLY IMPROVED SURVIVAL BENEFIT OF 19.3 MONTHS AND SIGNIFICANTLY DELAYED CLINICAL WORSENING IN RESCUE-ALS OPEN-LABEL EXTENSION TWO YEAR FOLLOW-UP

19.3 month significant survival difference for CNM-Au8® treated participants versus placebo 52% significant decreased risk of ALS clinical worsening events Over 475 years of CNM-Au8 treatment exposure without any identified safety signals SALT LAKE CITY, Aug. 29, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) through its wholly owned subsidiary Clene Nanomedicine Inc., today announced […]

| Comments Off on CLENE REPORTS SIGNIFICANTLY IMPROVED SURVIVAL BENEFIT OF 19.3 MONTHS AND SIGNIFICANTLY DELAYED CLINICAL WORSENING IN RESCUE-ALS OPEN-LABEL EXTENSION TWO YEAR FOLLOW-UP

BioTuesdays Features Halia Therapeutics CEO

In a recent interview with BioTuesdays, Halia and Co-Founder David Bearss, P.HD., said that the company is “growing to become a leader in targeting the NLRP3 inflammasome through a unique mechanism of action.” Closely-held Halia Therapeutics is developing a broad pipeline of novel therapies that are essential mediators of immune cell signaling with the potential […]

| Tagged | Comments Off on BioTuesdays Features Halia Therapeutics CEO

Final Demolition Efforts Underway at The Point

Crews to topple final guard tower and showcase sustainable demolition practices   WHAT: Members of the media are invited to get a close-up look at demolition efforts currently underway at The Point. Attendees will get exclusive views of the preserved prison chapel called the “Chapel by the Wayside” and the state-of-the-art crushing facility used to […]

| Comments Off on Final Demolition Efforts Underway at The Point

Halia Therapeutics Celebrates Grand Opening of Its Lehi, Utah Headquarters

It was standing room only Tuesday as Halia Therapeutics held a ribbon cutting for the opening of its new headquarters in Lehi, Utah – a 20,000 square foot state-of-art drug research and development facility. CEO and co-founder, David Bearss, Ph.D. welcomed guests and shared the Halia mission: to develop novel therapies to improve the lives […]

| Comments Off on Halia Therapeutics Celebrates Grand Opening of Its Lehi, Utah Headquarters

Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk

New collaboration increases access to genetic testing and can help identify patients with a high-risk for breast cancer SALT LAKE CITY, Aug. 22, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Onsite Women’s Health, a leading national provider of breast health services, today announced the […]

| Comments Off on Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk

BlueWind Medical’s Revi™ System Secures U.S. FDA De Novo Classification Grant for the Treatment of Urgency Incontinence

Revi redefines the treatment of Urgency Incontinence with a patient-centric implantable tibial neuromodulation solution that empowers patients

| Tagged | Comments Off on BlueWind Medical’s Revi™ System Secures U.S. FDA De Novo Classification Grant for the Treatment of Urgency Incontinence

Inherent Biosciences, Inc. Advances Fertility Solutions With Transformative Grant Funding From the NIH

A Leap Forward for Patients, a Promising Opportunity for Investors, and a Revolutionary Tool for Physicians

| Tagged | Comments Off on Inherent Biosciences, Inc. Advances Fertility Solutions With Transformative Grant Funding From the NIH

This plan to cut drug prices could result in lost jobs and fewer medicines

By Kelvyn Cullimore For the Deseret News

| Tagged | Comments Off on This plan to cut drug prices could result in lost jobs and fewer medicines

Myriad Genetics Advances Prostate Cancer Care with Addition of Absolute Risk Reduction to Prolaris®

Prolaris is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiation therapy1

| Tagged | Comments Off on Myriad Genetics Advances Prostate Cancer Care with Addition of Absolute Risk Reduction to Prolaris®

Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds

Recursion has predicted the protein target(s) for approximately 36 billion chemical compounds in the Enamine REAL Space, reported to be the world’s largest searchable chemical library. These advances were made possible by NVIDIA DGX Cloud supercomputing and the recent acquisition of Cyclica’s MatchMaker technology.

| Tagged | Comments Off on Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds

Utah Company Developing Origami-inspired Technology Awarded NSF Grant to Advance Robotic Surgery

August 7, 2023 Four years ago, Jacob Sheffield was building world-class carbon fiber travel guitars for adventurers journeying to places as remote as Everest and Antarctica. Ian Esplin was growing viruses in bioreactors and developing therapies to combat antibiotic-resistant pathogens. The two came together and co-founded Bloom Surgical with a goal to empower robotic surgeons […]

| Tagged | Comments Off on Utah Company Developing Origami-inspired Technology Awarded NSF Grant to Advance Robotic Surgery